Diligence memo · auto-generated · as of July 2, 2026
Agronomed Pharmaceuticals LLC
Agronomed Pharmaceuticals LLC looks over-valued against its niche peers and is dormant on financing cadence.
Businessfiled
Agronomed Pharmaceuticals LLC operates in Biotech / Pharma, based in EXTON.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Agronomed Pharmaceuticals LLC has raised $9.2M in disclosed capital across 3 recorded rounds, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).
Largest single filing: $3.9M on 2019-06-03.
Most recent recorded round closed around 2020-10-01.
Valuation (modeled)modeled
Provath models Agronomed Pharmaceuticals LLC at approximately $77M (range $1.6M–$567M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Over-valued. Modeled value is 2.28× the median modeled value of Seed Biotech / Pharma companies in 2019–2021 (15 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 14 months.
Last raise 5.7 yr ago; this sector typically re-raises about every 15 months.
Silent for over 3× the sector's normal cadence.
The last round was 1.8× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 61% of Biotech / Pharma peers (227 compared).
Modeled value ranks above 67% of those peers.
Closest niche peers: rMark Bio, Inc., Massive Bio, Inc., Light Bio, Inc., Cellix Biosciences, Inc., xD Bio, Inc..
Peoplefiled
2 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
Modeled above niche peers — valuation risk on entry.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.